Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study. - Yamout B; Alroughani R; Mohamed SFA; Al-Mahdawi AM; Khoury SJ; El Ayoubi N; Inshasi J; Alkhaboori J; Al-Asmi A; Gouider R; Aljarallah S; Alkhawajah N; et al. (Journal of neurology, neurosurgery, and psychiatry, 2026)